The former research also indicated that PVT1 could promote the chemoresistant ability to gemcitabine and cisplatin by regulating Wnt, autophagy, or PI3K/AKT signaling pathway in osteosarcoma or pancreatic cancer [22, 24, 42]. This evidence concerns the gene PVT1 and familial pancreatic carcinoma.